Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with kawasaki disease

Pediatric Cardiology

Volumn 31, Issue 8, 2010, Pages 1151-1156

  Yu, Hong Ren ^a   Kuo, Ho Chang ^a   Huang, Eng Yen ^a   Liang, Chi Di ^a   Hwang, Kao Pin ^a   Lin, I Chun ^a   Sheen, Jiunn Ming ^a   Wang, Tzu Jou ^a   Wang, Chih Lu ^a   Yang, Kuender D ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Clusterin; Coronary artery lesion; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CLUSTERIN; IMMUNOGLOBULIN;

ARTICLE; CHILD; CORONARY ARTERY DISEASE; CORONARY ARTERY LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHI-SQUARE DISTRIBUTION; CLUSTERIN; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 78449307440     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-010-9769-7     Document Type: Article

References (25)

1. JY Ban KL Yoon SK Kim S Kang JH Chung 2009 Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population Pediatr Cardiol 30 331 335 10.1007/s00246-008-9341-x 19048177
2. MH Biezeveld IM Kuipers J Geissler J Lam JJ Ottenkamp CE Hack, et al. 2003 Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease Lancet 361 1268 1270 1:CAS:528: DC%2BD3sXivV2lu7k%3D 10.1016/S0140-6736(03)12985-6 12699957
3. VG Cabana SS Gidding GS Getz J Chapman ST Shulman 1997 Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease Pediatr Res 42 651 655 1:CAS:528:DyaK2sXntleksrY%3D 10.1203/00006450-199711000-00017 9357939
4. YF Cheung TC Yung SC Tam MH Ho AK Chau 2004 Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis J Am Coll Cardiol 43 120 124 10.1016/j.jacc.2003.08. 030 14715193
5. SM Huang KP Weng JS Chang WY Lee SH Huang KS Hsieh 2008 Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: a pilot study Circ J 72 1583 1587 1:CAS:528:DC%2BD1cXht1KqtrjJ 10.1253/circj.CJ-08-0121 18758088
6. Y Ishikawa Y Akasaka T Ishii K Komiyama S Masuda N Asuwa, et al. 1998 Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta Arterioscler Thromb Vasc Biol 18 665 672 1:STN:280:DyaK1c3hsFWmuw%3D%3D 9555874
7. DE Jenne B Lowin MC Peitsch A Böttcher G Schmitz J Tschopp 1991 Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma J Biol Chem 266 11030 11036 1:CAS:528:DyaK3MXltFagurc%3D 1904058
8. T Kim W Choi CW Woo B Choi J Lee K Lee, et al. 2007 Predictive risk factors for coronary artery abnormalities in Kawasaki disease Eur J Pediatr 166 421 425 10.1007/s00431-006-0251-8 17033807
9. PA Krijnen HW Niessen 2007 The antiapoptotic protein clusterin protects cardiomyocytes against ischemia-induced cell death Am J Physiol Heart Circ Physiol 293 H3223 H3224 1:CAS:528:DC%2BD2sXhtlGhsbzL 10.1152/ajpheart.00964.2007 17989432
10. HC Kuo KD Yang CD Liang CN Bong HR Yu L Wang, et al. 2007 The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease Pediatr Allergy Immunol 18 354 359 10.1111/j.1399-3038.2007. 00516.x 17584314
11. HC Kuo CL Wang CD Liang HR Yu CF Huang L Wang, et al. 2009 Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease Pediatr Allergy Immunol 20 266 272 10.1111/j.1399-3038.2008.00779.x 19438983
12. KS Leskov DY Klokov J Li TJ Kinsella DA Boothman 2003 Synthesis and functional analyses of nuclear clusterin, a cell death protein J Biol Chem 278 11590 11600 1:CAS:528:DC%2BD3sXit1Kgtb0%3D 10.1074/jbc.M209233200 12551933
13. Y Li MB Sagar M Wassler H Shelat YJ Geng 2007 Apolipoprotein-J prevention of fetal cardiac myoblast apoptosis induced by ethanol Biochem Biophys Res Commun 357 157 161 1:CAS:528:DC%2BD2sXksFeisLs%3D 10.1016/j.bbrc.2007.03.109 17416353
14. JW Newburger JC Burns AS Beiser J Loscalzo 1991 Altered lipid profile after Kawasaki syndrome Circulation 84 625 631 1:STN:280:DyaK3Mzhs1yhtg%3D%3D 1860206
15. JW Newburger M Takahashi MA Gerber MH Gewitz LY Tani JC Burns, et al. 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2747 2771 10.1161/01.CIR. 0000145143.19711.78 15505111
16. S Nishimura M Zaitsu M Hara G Yokota M Watanabe Y Ueda, et al. 2003 A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease J Pediatr 143 357 362 1:CAS:528:DC%2BD3sXns1ehsLo%3D 10.1067/S0022-3476(03)00330-5 14517520
17. Y Nofech-Mozes BZ Garty 2003 Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms Pediatr Hematol Oncol 20 597 601 14578029
18. T Ohno H Igarashi K Inoue K Akazawa K Joho T Hara 2000 Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease Eur J Pediatr 159 424 429 1:CAS:528:DC%2BD3cXkvFWktrY%3D 10.1007/s004310051300 10867847
19. A Petzold A Altintas L Andreoni A Bartos A Berthele MA Blankenstein, et al. 2010 Neurofilament ELISA validation J Immunol Methods 352 23 31 1:CAS:528:DC%2BD1MXhsFyns7jM 10.1016/j.jim.2009.09.014 19857497
20. E Salo E Pesonen J Viikari 1991 Serum cholesterol levels during and after Kawasaki disease J Pediatr 119 557 561 1:STN:280:DyaK38%2FhsVGjtg%3D%3D 10.1016/S0022-3476(05)82404-7 1919886
21. N Schneider I Weigel K Werkmeister M Pischetsrieder 2010 Development and validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of lysozyme in cheese J Agric Food Chem 58 76 81 1:CAS:528:DC%2BD1MXhsValtLjE 10.1021/jf9025019 19919030
22. B Shannan M Seifert K Leskov J Willis D Boothman W Tilgen, et al. 2006 Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer Cell Death Differ 13 12 19 1:CAS:528:DC%2BD2MXht1yktbjM 10.1038/sj.cdd.4401779 16179938
23. T Shirasawa M Miyata H Eto N Hamada Y Akasaki T Miyauchi, et al. 2009 Deficiency of clusterin inhibits neointimal hyperplasia after vascular injury J Atheroscler Thromb 16 772 781 1:CAS:528:DC%2BC3cXhsV2js7w%3D 20032585
24. D Song Y Yeo K Ha G Jang J Lee K Lee, et al. 2009 Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age Eur J Pediatr 168 1315 1321 10.1007/s00431-009-0925-0 19159953
25. HR Yu HC Kuo JM Sheen L Wang IC Lin CL Wang, et al. 2009 A unique plasma proteomic profiling with imbalanced fibrinogen cascade in patients with Kawasaki disease Pediatr Allergy Immunol 20 699 707 10.1111/j.1399-3038.2008.00844.x 19170925